Radiopharm Theranostics Ltd
Clinical-stage company developing radiopharmaceuticals for cancer diagnosis and treatment.
RADX | US
Overview
Corporate Details
- ISIN(s):
- US75041J1016
- LEI:
- Country:
- United States of America
- Address:
- LEVEL 3, 62 LYGON STREET, 3053 CARLTON VIC
Description
Radiopharm Theranostics is a clinical-stage radiotherapeutics company developing a pipeline of products for both the diagnosis and treatment of cancer. The company focuses on creating first-in-class radiopharmaceuticals that address significant unmet needs in oncology. Its development strategy leverages a diverse range of proprietary platforms, including antibodies, nanobodies, peptides, and small molecules, to target novel cancer pathways. By avoiding common industry targets, the company aims to develop differentiated and precise therapies to improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Radiopharm Theranostics Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Radiopharm Theranostics Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Radiopharm Theranostics Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
